Skip to content

Clinical trials

Completed Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Completed Clear all

1,571 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200050
200130
200243
200340
200461
200564
200671
200770
200874
200973
201072
201180
201272
201392
201466
201573
201672
201765
201862
201946
202048
202139
202230
202323
202411
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,571

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center98
National Cancer Institute (NCI)90
Fred Hutchinson Cancer Center73
Memorial Sloan Kettering Cancer Center32
Masonic Cancer Center, University of Minnesota24
Novartis Pharmaceuticals24
Case Comprehensive Cancer Center23
National Heart, Lung, and Blood Institute (NHLBI)22
Roswell Park Cancer Institute22
Washington University School of Medicine22

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute1,571
Myelodysplastic Syndromes531
Precursor Cell Lymphoblastic Leukemia-Lymphoma490
Leukemia471
Leukemia, Lymphocytic, Chronic, B-Cell268
Lymphoma, Non-Hodgkin260
Congenital Abnormalities259
Hodgkin Disease229
Leukemia, Myelomonocytic, Chronic222
Multiple Myeloma215

Trials

Showing 76 to 100 of 1,571. Each trial links to its page on Pharma Observatory.

1,471 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.